Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor

NCT02444390 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

PROCEDURE: Biopsy

Sponsor

UNICANCER

Collaborators

[object Object]
[object Object]